The Royal Wolverhampton NHS Trust

The Royal Wolverhampton NHS Trust incorporates New Cross Hospital in Wolverhampton http://www.royalwolverhampton.nhs.uk/

View Trust Services

This trust offers the following services:

  • Diagnostic and pre-operative services:
    • On-site PET-CT facilities
    • On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
    • Routine Genetic Testing for Lynch Syndrome
  • Surgical services:
    • On-site thoracic surgical team
    • Robotic surgery
  • Advanced disease services:
    • Extended lymphadenectomy
  • Support service facilities:
    • Dedicated nurses for ERAS services
    • Availability of 24 hour palliative care advice
    • 7-day access to face-to-face palliative care services

Data Quality

All Patients: Trust Network National
Number of patients in Audit 261 3482 35779
Case ascertainment (%) Good Good Good
Data completeness of:
– Pre-treatment TNM (%) 94 83 86
– Performance status (%) 90 90 89
Patients having major resection: Trust Network National
Number of patients in Audit 127 2135 19631
ASA grade 1 (%) 2 5 9
ASA grade 2 (%) 39 53 53
ASA grade 3 (%) 28 34 31
ASA grade 4+ (%) 5 4 2
ASA grade not recorded (%) 27 4 4
Data completeness of:
7 Audit items for risk-adjustment (%) 66 87 87

Key:

> 80%
50 - 80%
< 50%

Management of all patients

All Patients: Trust Network National
Number of patients in Audit 261 3482 35779
Seen by Clinical Nurse Specialist (%) 89 89 88

Management of patients having major resection

Patients having major resection: Trust Network National
Number of patients in Audit 127 2135 19614
Distant metastases (%) 5 4 5
Urgent or emergency surgery (%) 18 24 15
At least 12 lymph nodes excised (%) 75 82 84
Laparoscopic surgery attempted (%) 70 72 72
Risk-adjusted length of stay > 5 days (%) 55 49 55
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 94 N/A 10747
Adjuvant chemotherapy (%) 73 N/A 62
Patients receiving chemotherapy after major resection for stage III colon cancer: Trust Network National
Number of patients in audit 69 N/A 6608
Severe acute toxicity after adjuvant chemotherapy (%) 25 N/A 22

Rectal cancer patients

Patients having major resection: Trust Network National
Number of patients in Audit 31 N/A 4251
Neoadjuvant therapy (%) 34 N/A 33
Circumferential resection margin: Recorded (%) 90 88 89
Circumferential resection margin: Negative (%) 87 81 83
Rectal volume 36 N/A 4377
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate 217 2273 19644
APER/Hartmanns (%) 36 38 37

Compare trust outcomes